Orgenesis Inc. Files 8-K for Material Agreement
Ticker: ORGS · Form: 8-K · Filed: Mar 1, 2024 · CIK: 1460602
| Field | Detail |
|---|---|
| Company | Orgenesis INC. (ORGS) |
| Form Type | 8-K |
| Filed Date | Mar 1, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $8,340,000 Million, $3,300,000, $750,000, $6,840,000, $250,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing
TL;DR
Orgenesis filed an 8-K on Feb 26 for a new material agreement.
AI Summary
Orgenesis Inc. filed an 8-K on March 1, 2024, reporting a material definitive agreement entered into on February 26, 2024. The filing also includes financial statements and exhibits. The company is incorporated in Nevada and its principal executive offices are located in Germantown, MD.
Why It Matters
This 8-K filing indicates a significant new agreement for Orgenesis Inc., which could impact its business operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's stock price.
Key Players & Entities
- Orgenesis Inc. (company) — Registrant
- February 26, 2024 (date) — Date of earliest event reported
- March 1, 2024 (date) — Date of report
- Nevada (jurisdiction) — State of incorporation
- Germantown, MD (location) — Principal executive offices
FAQ
What type of material definitive agreement did Orgenesis Inc. enter into?
The filing does not specify the exact nature of the material definitive agreement, only that one was entered into on February 26, 2024.
When was this 8-K filing submitted to the SEC?
The 8-K filing was submitted on March 1, 2024.
Where are Orgenesis Inc.'s principal executive offices located?
Orgenesis Inc.'s principal executive offices are located at 20271 Goldenrod Lane, Germantown, MD 20876.
What is Orgenesis Inc.'s IRS Employer Identification Number?
Orgenesis Inc.'s IRS Employer Identification Number is 98-0583166.
What is the SIC code for Orgenesis Inc.?
The Standard Industrial Classification (SIC) code for Orgenesis Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 1,508 words · 6 min read · ~5 pages · Grade level 15.5 · Accepted 2024-03-01 16:05:16
Key Financial Figures
- $8,340,000 Million — n the Binding Term Sheet: Overview of $8,340,000 Million Transaction and $3,300,000 in Working C
- $3,300,000 — w of $8,340,000 Million Transaction and $3,300,000 in Working Capital Commitment Up-fron
- $750,000 — Sheet, Germfree paid Orgenesis Maryland $750,000 on February 27, 2024, which amount will
- $6,840,000 — free will pay Orgenesis an aggregate of $6,840,000, which will be payable within five days
- $250,000 — ermfree will agree to pay an additional $250,000 upon the signing of the Definitive Agre
Filing Documents
- form8-k.htm (8-K) — 64KB
- ex10-1.htm (EX-10.1) — 79KB
- 0001493152-24-008483.txt ( ) — 323KB
- orgs-20240226.xsd (EX-101.SCH) — 3KB
- orgs-20240226_lab.xml (EX-101.LAB) — 33KB
- orgs-20240226_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: March 1, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary